Medicare Enrolled
Dr. Ashok Joshi, M.D.
Internal Medicine · North Billerica, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Joshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Joshi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Joshi
Dr. Ashok Joshi is an internal medicine specialist in North Billerica, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Joshi performed 3,961 Medicare services across 2,049 unique beneficiaries.
Between the years covered by Open Payments, Dr. Joshi received a total of $17,759 from 47 pharmaceutical and/or device companies across 609 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Joshi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in MA
$17,759 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,961
Medicare services
Top 4% in MA for internal medicine
2,049
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~198 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
843 | $90 | $397 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
598 | $60 | $274 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
335 | $10 | $44 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
317 | $10 | $90 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
300 | $3 | $15 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
258 | $6 | $20 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
238 | $4 | $15 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
230 | $2 | $15 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
179 | $142 | $225 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
145 | $31 | $60 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
99 | $72 | $130 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
75 | $12 | $45 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
70 | $32 | $150 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
56 | $31 | $60 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
48 | $281 | $453 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
46 | $22 | $46 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
30 | $16 | $35 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $142 | $450 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
20 | $181 | $275 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
19 | $87 | $250 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
16 | $16 | $25 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
11 | $21 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,759
Total received (2018-2024)
Avg $2,537/year across 7 years
Top 9% in MA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
609
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,828 (66.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,551 (31.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$380 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,030
2023
$1,605
2022
$1,425
2021
$1,491
2020
$1,230
2019
$2,136
2018
$7,842
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$438
Janssen Pharmaceuticals, Inc
$306
Otsuka America Pharmaceutical, Inc.
$238
Amgen Inc.
$186
Sumitomo Pharma America, Inc.
$114
Bayer Healthcare Pharmaceuticals Inc.
$112
Novo Nordisk Inc
$106
PFIZER INC.
$101
Lilly USA, LLC
$96
Merck Sharp & Dohme LLC
$78
Exact Sciences Corporation
$52
SHIELD THERAPEUTICS INC
$38
Lundbeck LLC
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
GlaxoSmithKline, LLC.
$24
Tempus AI, Inc
$23
Currax Pharmaceuticals LLC
$17
Abbott Laboratories
$16
ABBVIE INC.
$15
Echosens North America, Inc.
$15
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$6,501
AstraZeneca Pharmaceuticals LP
$1,870
PFIZER INC.
$1,363
GlaxoSmithKline, LLC.
$884
Lilly USA, LLC
$866
Novo Nordisk Inc
$707
Boehringer Ingelheim Pharmaceuticals, Inc.
$588
Janssen Pharmaceuticals, Inc
$468
Astellas Pharma US Inc
$447
Novartis Pharmaceuticals Corporation
$415
ABBVIE INC.
$314
Otsuka America Pharmaceutical, Inc.
$312
Bayer Healthcare Pharmaceuticals Inc.
$275
AbbVie Inc.
$268
Merck Sharp & Dohme Corporation
$240
Amarin Pharma Inc.
$213
Bayer HealthCare Pharmaceuticals Inc.
$203
Biohaven Pharmaceuticals, Inc.
$170
Merck Sharp & Dohme LLC
$163
SANOFI-AVENTIS U.S. LLC
$156
Daiichi Sankyo Inc.
$148
Alkermes, Inc.
$130
Sumitomo Pharma America, Inc.
$114
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$107
Teva Pharmaceuticals USA, Inc.
$95
Shield Therapeutics Inc
$95
Exact Sciences Corporation
$75
Ultragenyx Pharmaceutical Inc.
$67
Allergan Inc.
$61
VBI Vaccines (Delaware) Inc.
$57
Lundbeck LLC
$54
SHIELD THERAPEUTICS INC
$38
Allergan, Inc.
$25
IDORSIA PHARMACEUTICALS US INC
$25
Endo Pharmaceuticals Inc.
$24
Tempus AI, Inc
$23
Sanofi Pasteur Inc.
$22
E.R. Squibb & Sons, L.L.C.
$22
Sunovion Pharmaceuticals Inc.
$21
Dynavax Technologies Corporation
$19
Genentech USA, Inc.
$18
Currax Pharmaceuticals LLC
$17
Phadia US Inc.
$17
Abbott Laboratories
$16
CooperSurgical, Inc.
$15
Echosens North America, Inc.
$15
Agile Therapeutics, Inc.
$12
Top 3 companies account for 54.8% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · BASAGLAR · BEVESPI AEROSPHERE · BREATHTEK · BREO · BREZTRI · BRILINTA · BYDUREON · CHANTIX · CONTRAVE · CREON · Cologuard Collection Kit · Crysvita · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 3 · FibroScan · GARDASIL · GARDASIL 9 · GEMTESA · HUMALOG · Heplisav-B · INJECTAFER · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JYNARQUE · Kerendia · LEQVIO · LINZESS · LYRICA · MOUNJARO · MYRBETRIQ · Mirena · NASCOBAL · NURTEC ODT · OFEV · Otezla · Ozempic · PARAGARD T 380A · PAXLOVID · PNEUMOVAX 23 · PRALUENT · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PreHevbrio · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Twirla · UBRELVY · Utibron · VIAGRA · VIVITROL · VRAYLAR · Vascepa · Victoza · XARELTO · XIFAXAN · XIFAXANIBSD · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (67%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in MA.
Geographic Context
Internal medicine physicians within 10 mi
5,403
Per 100K population
332.9
County median income
$126,779
Nearest hospital
BEDFORD VA MEDICAL CENTER
5.5 mi
5.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Joshi is a clinical cardiology specialist, with above-average Medicare volume (top 4% in MA), with low-engagement industry engagement in the top 9% of MA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Joshi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Joshi performed 843 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Joshi receive payments from pharmaceutical companies?
Yes. Dr. Joshi received a total of $17,759 from 47 companies across 609 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Joshi's costs compare to other internal medicine physicians in North Billerica?
Dr. Joshi's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Joshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in North Billerica
Browse internal medicine physicians in North Billerica ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in MA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in MA
Which MA internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology